Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer

NCT00381888 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Endometrial Cancer
Fallopian Tube Cancer
Ovarian Cancer
Sarcoma
Thromboembolism
Vaginal Cancer
Vulvar Cancer

Interventions

DRUG: fondaparinux sodium

Sponsor

Masonic Cancer Center, University of Minnesota